Stock Track | Amphastar Pharmaceuticals Plunges 16.19% After-Hours on Q4 Earnings and Revenue Miss

Stock Track02-27

Amphastar Pharmaceuticals' stock experienced a significant after-hours plunge of 16.19% following the release of its fourth-quarter financial results, which fell short of analyst expectations across multiple key metrics.

The company reported adjusted earnings per share of $0.73, missing the consensus estimate of $0.92 by 20.82%. This represents a 20.65% decrease compared to earnings of $0.92 per share from the same period last year. Revenue also disappointed at $183.105 million, falling 3.87% below the $190.480 million estimate and marking a 1.83% year-over-year decline.

Other financial metrics showed similar weakness, with adjusted net income of $34.158 million missing the $43.6 million estimate. The across-the-board misses in both earnings and revenue, coupled with year-over-year declines, prompted the sharp sell-off in post-market trading.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1148691608?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-27 05:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1148691608","market":"us","top_or_hot":-1,"title":"Stock Track | Amphastar Pharmaceuticals Plunges 16.19% After-Hours on Q4 Earnings and Revenue Miss","media":"Stock Track","content":"<p>Amphastar Pharmaceuticals' stock experienced a significant after-hours plunge of 16.19% following the release of its fourth-quarter financial results, which fell short of analyst expectations across multiple key metrics.</p><p>The company reported adjusted earnings per share of $0.73, missing the consensus estimate of $0.92 by 20.82%. This represents a 20.65% decrease compared to earnings of $0.92 per share from the same period last year. Revenue also disappointed at $183.105 million, falling 3.87% below the $190.480 million estimate and marking a 1.83% year-over-year decline.</p><p>Other financial metrics showed similar weakness, with adjusted net income of $34.158 million missing the $43.6 million estimate. The across-the-board misses in both earnings and revenue, coupled with year-over-year declines, prompted the sharp sell-off in post-market trading.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Amphastar Pharmaceuticals Plunges 16.19% After-Hours on Q4 Earnings and Revenue Miss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Amphastar Pharmaceuticals Plunges 16.19% After-Hours on Q4 Earnings and Revenue Miss\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-27 05:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Amphastar Pharmaceuticals' stock experienced a significant after-hours plunge of 16.19% following the release of its fourth-quarter financial results, which fell short of analyst expectations across multiple key metrics.</p><p>The company reported adjusted earnings per share of $0.73, missing the consensus estimate of $0.92 by 20.82%. This represents a 20.65% decrease compared to earnings of $0.92 per share from the same period last year. Revenue also disappointed at $183.105 million, falling 3.87% below the $190.480 million estimate and marking a 1.83% year-over-year decline.</p><p>Other financial metrics showed similar weakness, with adjusted net income of $34.158 million missing the $43.6 million estimate. The across-the-board misses in both earnings and revenue, coupled with year-over-year declines, prompted the sharp sell-off in post-market trading.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AMPH","symbol_name":"Amphastar Pharmaceuticals","start_time":0,"source_url":"","article_id":"1148691608","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1148691608","pubTimestamp":1772141616,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Amphastar Pharmaceuticals' stock experienced a significant after-hours plunge of 16.19% following the release of its fourth-quarter financial results, which fell short of analyst expectations across...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"AMPH":"Amphastar Pharmaceuticals"},"translate_title":"个股追踪|Amphastar Pharmaceuticals盘后暴跌16.19%因Q4盈利和营收未达预期","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMPH":1},"content_text":"Amphastar Pharmaceuticals' stock experienced a significant after-hours plunge of 16.19% following the release of its fourth-quarter financial results, which fell short of analyst expectations across multiple key metrics.The company reported adjusted earnings per share of $0.73, missing the consensus estimate of $0.92 by 20.82%. This represents a 20.65% decrease compared to earnings of $0.92 per share from the same period last year. Revenue also disappointed at $183.105 million, falling 3.87% below the $190.480 million estimate and marking a 1.83% year-over-year decline.Other financial metrics showed similar weakness, with adjusted net income of $34.158 million missing the $43.6 million estimate. The across-the-board misses in both earnings and revenue, coupled with year-over-year declines, prompted the sharp sell-off in post-market trading.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1148691608","isCrawlerRequest":true}